AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28
Virological response in multidrug-experienced HIV-1-infected subjects failing highly active combination regimens after shifting from lamivudine to didanosine
Authors: Rusconi, S Catamancio, SL Citterio, P Bulgheroni, E Kurtagic, S Galazzi, M Croce, F Moroni, M Galli, M
Citation: S. Rusconi et al., Virological response in multidrug-experienced HIV-1-infected subjects failing highly active combination regimens after shifting from lamivudine to didanosine, ANTIVIR TH, 6(1), 2001, pp. 41-46
Selective enhancement of gene transfer by steroid-mediated gene delivery
Authors: Rebuffat, A Bernasconi, A Ceppi, M Wehrli, H Verca, SB Ibrahim, M Frey, BM Frey, FJ Rusconi, S
Citation: A. Rebuffat et al., Selective enhancement of gene transfer by steroid-mediated gene delivery, NAT BIOTECH, 19(12), 2001, pp. 1155-1161
Predictive role of the three-month CD4 cell count in the long-term clinical outcome of the first HAART regimen
Authors: Monforte, AD Adorni, F Meroni, L Bini, T Testa, L Chiesa, E Melzi, S Rusconi, S Sollima, S Galli, M Moroni, M
Citation: Ad. Monforte et al., Predictive role of the three-month CD4 cell count in the long-term clinical outcome of the first HAART regimen, BIOMED PHAR, 55(1), 2001, pp. 16-22
Expression level-dependent contribution of glucocorticoid receptor domainsfor functional interaction with STAT5
Authors: Doppler, W Windegger, M Soratroi, C Tomasi, J Lechner, J Rusconi, S Cato, ACB Almlof, T Liden, J Okret, S Gustafsson, JA Richard-Foy, H Starr, DB Klocker, H Edwards, D Geymayer, S
Citation: W. Doppler et al., Expression level-dependent contribution of glucocorticoid receptor domainsfor functional interaction with STAT5, MOL CELL B, 21(9), 2001, pp. 3266-3279
Differential disappearance of inhibitory natural killer cell receptors during HAART and possible impairment of HIV-1-specific CD8 cytotoxic T lymphocytes
Authors: Costa, P Rusconi, S Mavilio, D Fogli, M Murdaca, G Pende, D Mingari, MC Galli, M Moretta, L De Maria, A
Citation: P. Costa et al., Differential disappearance of inhibitory natural killer cell receptors during HAART and possible impairment of HIV-1-specific CD8 cytotoxic T lymphocytes, AIDS, 15(8), 2001, pp. 965-974
In vitro evolution of the human immunodeficiency virus type 1 Gag-proteaseregion and maintenance of reverse transcriptase resistance following prolonged drug exposure
Authors: Catamancio, SL De Pasquale, MP Citterio, P Kurtagic, S Galli, M Rusconi, S
Citation: Sl. Catamancio et al., In vitro evolution of the human immunodeficiency virus type 1 Gag-proteaseregion and maintenance of reverse transcriptase resistance following prolonged drug exposure, J CLIN MICR, 39(3), 2001, pp. 1124-1129
Transactivation specificity of glucocorticoid versus progesterone receptors - Role of functionally different interactions of transcription factors with amino- and carboxyl-terminal receptor domains
Authors: Song, LN Huse, B Rusconi, S Simons, SS
Citation: Ln. Song et al., Transactivation specificity of glucocorticoid versus progesterone receptors - Role of functionally different interactions of transcription factors with amino- and carboxyl-terminal receptor domains, J BIOL CHEM, 276(27), 2001, pp. 24806-24816
Prevalence of multiple dideoxynucleoside analogue resistance (MddNR) in a multicenter cohort of HIV-1-infected Italian patients with virologic failure
Authors: Balotta, C Violin, M Monno, L Bagnarelli, P Riva, C Facchi, G Berlusconi, A Lippi, M Rusconi, S Clementi, M Galli, M Angarano, G Moroni, M
Citation: C. Balotta et al., Prevalence of multiple dideoxynucleoside analogue resistance (MddNR) in a multicenter cohort of HIV-1-infected Italian patients with virologic failure, J ACQ IMM D, 24(3), 2000, pp. 232-240
A genotypic analysis of patients receiving Zidovudine with either Lamivudine, Didanosine or Zalcitabine dual therapy using the LiPA point mutation assay to detect genotypic variation at codons 41, 69, 70, 74, 184 and 215
Authors: Rusconi, S Catamancio, SL Sheridan, F Parker, D
Citation: S. Rusconi et al., A genotypic analysis of patients receiving Zidovudine with either Lamivudine, Didanosine or Zalcitabine dual therapy using the LiPA point mutation assay to detect genotypic variation at codons 41, 69, 70, 74, 184 and 215, J CLIN VIRO, 19(3), 2000, pp. 135-142
In vitro inhibition of HIV-1 by Met-SDF-1 beta alone or in combination with antiretroviral drugs
Authors: Rusconi, S Merill, DP Catamancio, SL Citterio, P Bulgheroni, E Croce, F Chou, TC Yang, OO Herrmann, SH Galli, M Hirsch, MS
Citation: S. Rusconi et al., In vitro inhibition of HIV-1 by Met-SDF-1 beta alone or in combination with antiretroviral drugs, ANTIVIR TH, 5(3), 2000, pp. 199-204
Prevalence of transmitted nucleoside analogue-resistant HIV-1 strains and pre-existing mutations in pol reverse transcriptase and protease region: outcome after treatment in recently infected individuals
Authors: Balotta, C Berlusconi, A Pan, A Violin, M Riva, C Colombo, MC Gori, A Papagno, L Corvasce, S Mazzucchelli, R Facchi, G Velleca, R Saporetti, G Galli, M Rusconi, S Moroni, N
Citation: C. Balotta et al., Prevalence of transmitted nucleoside analogue-resistant HIV-1 strains and pre-existing mutations in pol reverse transcriptase and protease region: outcome after treatment in recently infected individuals, ANTIVIR TH, 5(1), 2000, pp. 7-14
Persisting HIV-1 replication triggered by acute hepatitis A virus infection
Authors: Ridolfo, AL Rusconi, S Antinori, S Balotta, C Galli, M
Citation: Al. Ridolfo et al., Persisting HIV-1 replication triggered by acute hepatitis A virus infection, ANTIVIR TH, 5(1), 2000, pp. 15-17
Clinical impact of anti retroviral resistance testing: current problems and future directions
Authors: Rusconi, S Moroni, M
Citation: S. Rusconi et M. Moroni, Clinical impact of anti retroviral resistance testing: current problems and future directions, INT J ANT A, 16(4), 2000, pp. 425-427
Comparison of lipid-mediated and adenoviral gene transfer in human monocyte-derived macrophages and COS-7 cells
Authors: Heider, H Verca, SB Rusconi, S Asmis, R
Citation: H. Heider et al., Comparison of lipid-mediated and adenoviral gene transfer in human monocyte-derived macrophages and COS-7 cells, BIOTECHNIQU, 28(2), 2000, pp. 260
Prevalence of HIV-1 resistant strains in recent seroconverters
Authors: Balotta, C Berlusconi, A Pan, A Violin, M Riva, C Gori, A Corvasce, S Mazzucchelli, R Facchi, G Velleca, R Senese, D Deho, L Galli, M Rusconi, S Moroni, M
Citation: C. Balotta et al., Prevalence of HIV-1 resistant strains in recent seroconverters, J BIOL REG, 14(1), 2000, pp. 51-57
Quantitative evaluation of the recombinant HIV-1 phenotype to protease inhibitors by a single-step strategy
Authors: Menzo, S Rusconi, S Monachetti, A Colombo, MC Violin, M Bagnarelli, P Varaldo, PE Moroni, M Galli, M Balotta, C Clementi, M
Citation: S. Menzo et al., Quantitative evaluation of the recombinant HIV-1 phenotype to protease inhibitors by a single-step strategy, AIDS, 14(9), 2000, pp. 1101-1110
Response to antiretroviral therapy in a patient with an uncommon codon 69 insertion in the human immunodeficiency virus type 1 reverse transcriptase
Authors: Bonfanti, P Faggion, I Catamancio, SL Violin, M Balotta, C Rusconi, S
Citation: P. Bonfanti et al., Response to antiretroviral therapy in a patient with an uncommon codon 69 insertion in the human immunodeficiency virus type 1 reverse transcriptase, ANTIM AG CH, 44(6), 2000, pp. 1767-1768
Susceptibility to PNU-140690 (Tipranavir) of human immunodeficiency virus type 1 isolates derived from patients with multidrug resistance to other protease inhibitors
Authors: Rusconi, S Catamancio, SLA Citterio, P Kurtagic, S Violin, M Balotta, C Moroni, M Galli, M D'Arminio-Monforte, A
Citation: S. Rusconi et al., Susceptibility to PNU-140690 (Tipranavir) of human immunodeficiency virus type 1 isolates derived from patients with multidrug resistance to other protease inhibitors, ANTIM AG CH, 44(5), 2000, pp. 1328-1332
Combination of CCR5 and CXCR4 inhibitors in therapy of human immunodeficiency virus type 1 infection: In vitro studies of mixed virus infections
Authors: Rusconi, S Catamancio, SL Citterio, P Bulgheroni, E Croce, F Herrmann, SH Offord, RE Galli, M Hirsch, MS
Citation: S. Rusconi et al., Combination of CCR5 and CXCR4 inhibitors in therapy of human immunodeficiency virus type 1 infection: In vitro studies of mixed virus infections, J VIROLOGY, 74(19), 2000, pp. 9328-9332
Evidence of stavudine-related phenotypic resistance among zidovudine-pretreated HIV-1-infected subjects receiving a therapeutic regimen of stavudine plus lamivudine
Authors: Milazzo, L Rusconi, S Testa, L La Seta-Catamancio, S Galazzi, M Kurtagic, S Citterio, P Gianotto, M Grassini, A Adorni, F d'Arminio-Monforte, A Galli, M Moroni, M
Citation: L. Milazzo et al., Evidence of stavudine-related phenotypic resistance among zidovudine-pretreated HIV-1-infected subjects receiving a therapeutic regimen of stavudine plus lamivudine, J ACQ IMM D, 22(1), 1999, pp. 101-103
Altered signaling lymphocytic activation molecule (SLAM) expression in HIVinfection and redirection of HIV-specific responses via SLAM triggering
Authors: Meroni, L Fusi, ML Varchetta, S Biasin, M Rusconi, S Villa, ML De Vries, JE Aversa, G Galli, M Clerici, M
Citation: L. Meroni et al., Altered signaling lymphocytic activation molecule (SLAM) expression in HIVinfection and redirection of HIV-specific responses via SLAM triggering, CLIN IMMUNO, 92(3), 1999, pp. 276-284
Anti-HIV-1 intermittent drug intensification in HIV-1-infected patients naive for antiretrovirals
Authors: Rusconi, S Argenteri, B Galli, M d'Arminio-Monforte, A Moroni, M
Citation: S. Rusconi et al., Anti-HIV-1 intermittent drug intensification in HIV-1-infected patients naive for antiretrovirals, ANTIVIR TH, 4(3), 1999, pp. 183-184
Aminooxypentane-RANTES, an inhibitor of R5 human immunodeficiency virus type 1, increases the interferon gamma to interleukin 10 ratio without impairing cellular proliferation
Authors: Rusconi, S La Seta-Catamancio, S Kurtagic, S Galazzi, M Arienti, D Trabattoni, D Wilken, J Thompson, DA Offord, RE Galli, M Clerici, M
Citation: S. Rusconi et al., Aminooxypentane-RANTES, an inhibitor of R5 human immunodeficiency virus type 1, increases the interferon gamma to interleukin 10 ratio without impairing cellular proliferation, AIDS RES H, 15(10), 1999, pp. 861-867
Effective inhibition of HIV-1 isolated from patients with acute primary HIV-1 infection by aminooxypentane-RANTES
Authors: Rusconi, S Merrill, DP La Seta-Catamancio, S Citterio, P Offord, RE Hirsch, MS
Citation: S. Rusconi et al., Effective inhibition of HIV-1 isolated from patients with acute primary HIV-1 infection by aminooxypentane-RANTES, AIDS, 13(9), 1999, pp. 1144-1145
CD4 cell counts at the third month of HAART may predict clinical failure
Authors: Monforte, AD Testori, V Adorni, F Castelnuovo, B Bini, T Testa, L Moscatelli, G Chiesa, E Rusconi, S Abeli, C Sollima, S Musicco, M Meroni, L Galli, M Moroni, M
Citation: Ad. Monforte et al., CD4 cell counts at the third month of HAART may predict clinical failure, AIDS, 13(13), 1999, pp. 1669-1676
Risultati: 1-25 | 26-28